[1] Singal AK, Bataller R, Ahn J, et al. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol, 2018, 113: 175-194.
[2] Witkiewitz K, Kranzler HR, Hallgren KA, et al. Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder. J Gen Intern Med, 2021, 36: 404-412.
[3] Knox J, Scodes J, Wall M, et al. Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population. Drug Alcohol Depend, 2019, 197: 228-235.
[4] Rehm J, Taylor B, Mohapatra S, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev, 2010, 29: 437-445.
[5] Altamirano J, Lpez-Pelayo H, Michelena J, et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival. Hepatology, 2017, 66: 1842-1853.
[6] Kuitunen-Paul S, Roerecke M. Alcohol Use Disorders Identification Test (AUDIT) and mortality risk: a systematic review and meta-analysis. J Epidemiol Community Health, 2018, 72: 856-863.
[7] Caputo F, Domenicali M, Bernardi M. Diagnosis and Treatment of Alcohol Use Disorder in Patients With End-Stage Alcoholic Liver Disease. Hepatology, 2019, 70: 410-417.
[8] Dulin PL, Alvarado CE, Fitterling JM, et al. Comparisons of Alcohol Consumption by Time-Line Follow Back vs. Smartphone-Based Daily Interviews. Addict Res Theory, 2017, 25: 195-200.
[9] Arnts J, Vanlerberghe BTK, Roozen S, et al. Diagnostic Accuracy of Biomarkers of Alcohol Use in Patients With Liver Disease: A Systematic Review. Alcohol Clin Exp Res, 2021, 45: 25-37.
[10] Wang Y, Fridberg DJ, Shortell DD, et al. Wrist-worn alcohol biosensors: Applications and usability in behavioral research. Alcohol, 2021, 92: 25-34. |
